FIS Cuts Target Price to $48 From $73
FIS•Related News
Vertex Pharma rises after rival genetic disorder drug setback
VRTX•
Fulcrum CFO Alan Musso takes over as principal accounting officer after Tourangeau exit
FULC•
Intel plans $15 billion share sale as turnaround rally lifts stock
INTC•
Instacart partners with Academy Sports + Outdoors for same-day delivery on marketplace
CART•
BOS wins USD 1.8 million purchase order for electromechanical connectors from new customer
BOSC•